This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic
characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17
years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)